DR Horton: Upgrades, Downgrades

DR Horton upgraded at Ticonderoga from Neutral to Buy. $13 price target. Operating metrics are improving.

Author:
Publish date:: Aug 25, 2010 9:15 AM EDT

NEW YORK (TheStreet) -- CHANGE IN RATINGS

DR Horton

upgraded at Ticonderoga from Neutral to Buy. $13 price target. Operating metrics are improving.

Corning

upgraded at Oppenheimer from Perform to Outperform. $20 price target. Investors are focused on the LCD inventory correction, which should be over soon. Rather, the company has multiple potential catalysts.

Intuitive Surgical

(ISRG) - Get Report

upgraded at Wells. ISRG was upgraded to Outperform. Company still has room to grow across the globe and management will likely buy back more stock.

Medtronic

(MDT) - Get Report

downgraded at Wells to Market Perform. Guidance appears aggressive as demand in spinal and other areas could continue to deteriorate.

Medtronic

(MDT) - Get Report

downgraded at William Blair from Outperform to Market Perform. Company had a weak quarter and cut its outlook.

Annaly Capital

(NLY) - Get Report

downgraded at JMP from Outperform to Market Perform. Agency MBS investments have underperformed. Company also facing higher pre-payment rates.

Quality Systems

(QSII)

upgraded at JMP from Market Perform to Outperform. $72 price target. Channel checks suggest an uptick in deal activity.

STOCK COMMENTS / EPS CHANGES

Burger King

(BKC)

estimates lowered at Oppenheimer through 2011. Company is realizing lower restaurant sales and margins. Perform rating.

J. Crew

(JCG)

estimates, target lowered at Piper. Shares of JCG now seen reaching $42. Estimates also cut, as the company faces difficult sales comps. Overweight rating.

This article was written by a staff member of TheStreet.